Brentuximab vedotin
id:
brentuximab-vedotin-173-14759860
title:
Brentuximab vedotin
text:
Brentuximab vedotin, sold under the brand name Adcetris, is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (ALCL), a type of T cell non-Hodgkin lymphoma. It selectively targets tumor cells expressing the CD30 antigen, a defining marker of Hodgkin lymphoma and ALCL. The drug is being jointly marketed by Millennium Pharmaceuticals outside the US and by Seagen in the US.
brand slug:
wiki
category slug:
encyclopedia
description:
Pharmaceutical drug
original url:
https://en.wikipedia.org/wiki/Brentuximab_vedotin
date created:
2009-11-03T20:04:57Z
date modified:
2024-09-02T15:03:47Z
main entity:
{"identifier":"Q422324","url":"https://www.wikidata.org/entity/Q422324"}
image:
fields total:
13
integrity:
15